Yüklüyor......

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma

Cancer immunotherapy has made tremendous progress, including promising results in patients with malignant gliomas. Nonetheless, the immunological microenvironment of the brain and tumors arising therein is still believed to be suboptimal for sufficient antitumor immune responses for a variety of rea...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ahn, Brian J., Pollack, Ian F., Okada, Hideho
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2013
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3875944/
https://ncbi.nlm.nih.gov/pubmed/24202450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers5041379
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!